Annual Working Capital
$16.33 M
-$24.99 M-60.48%
31 December 2023
Summary:
BioLineRx annual working capital is currently $16.33 million, with the most recent change of -$24.99 million (-60.48%) on 31 December 2023. During the last 3 years, it has risen by +$4.09 million (+33.43%). BLRX annual working capital is now -65.75% below its all-time high of $47.69 million, reached on 31 December 2021.BLRX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$12.89 M
-$5.71 M-30.69%
30 September 2024
Summary:
BioLineRx quarterly working capital is currently $12.89 million, with the most recent change of -$5.71 million (-30.69%) on 30 September 2024. Over the past year, it has dropped by -$1.19 million (-8.47%). BLRX quarterly working capital is now -77.45% below its all-time high of $57.16 million, reached on 30 June 2021.BLRX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLRX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -60.5% | -8.5% |
| 3 y3 years | +33.4% | -75.5% |
| 5 y5 years | -35.3% | -40.4% |
BLRX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -65.8% | +33.4% | -75.5% | +198.4% |
| 5 y | 5 years | -65.8% | +33.4% | -77.5% | +198.4% |
| alltime | all time | -65.8% | +33.4% | -77.5% | +198.4% |
BioLineRx Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $12.89 M(-30.7%) |
| June 2024 | - | $18.59 M(+330.6%) |
| Mar 2024 | - | $4.32 M(-73.6%) |
| Dec 2023 | $16.33 M(-60.5%) | $16.33 M(+16.0%) |
| Sept 2023 | - | $14.08 M(-36.7%) |
| June 2023 | - | $22.25 M(-31.1%) |
| Mar 2023 | - | $32.29 M(-21.9%) |
| Dec 2022 | $41.32 M(-13.3%) | $41.32 M(-17.0%) |
| Sept 2022 | - | $49.81 M(+44.5%) |
| June 2022 | - | $34.47 M(-17.6%) |
| Mar 2022 | - | $41.84 M(-12.3%) |
| Dec 2021 | $47.69 M(+289.6%) | $47.69 M(-9.2%) |
| Sept 2021 | - | $52.53 M(-8.1%) |
| June 2021 | - | $57.16 M(+16.3%) |
| Mar 2021 | - | $49.14 M(+301.5%) |
| Dec 2020 | $12.24 M(-24.6%) | $12.24 M(+11.8%) |
| Sept 2020 | - | $10.95 M(-33.4%) |
| June 2020 | - | $16.45 M(+58.5%) |
| Mar 2020 | - | $10.37 M(-36.1%) |
| Dec 2019 | $16.24 M(-35.6%) | $16.24 M(-24.8%) |
| Sept 2019 | - | $21.61 M(-21.8%) |
| June 2019 | - | $27.65 M(-17.5%) |
| Mar 2019 | - | $33.51 M(+32.8%) |
| Dec 2018 | $25.23 M(-42.2%) | $25.23 M(-21.6%) |
| Sept 2018 | - | $32.18 M(-14.1%) |
| June 2018 | - | $37.46 M(-4.8%) |
| Mar 2018 | - | $39.36 M(-9.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $43.65 M(+34.6%) | $43.65 M(-13.2%) |
| Sept 2017 | - | $50.32 M(+4.3%) |
| June 2017 | - | $48.25 M(+82.3%) |
| Mar 2017 | - | $26.47 M(-18.4%) |
| Dec 2016 | $32.44 M(-28.0%) | $32.44 M(-10.0%) |
| Sept 2016 | - | $36.05 M(-9.6%) |
| June 2016 | - | $39.89 M(-7.9%) |
| Mar 2016 | - | $43.31 M(-3.8%) |
| Dec 2015 | $45.04 M(+39.7%) | $45.04 M(-6.7%) |
| Sept 2015 | - | $48.30 M(-6.3%) |
| June 2015 | - | $51.54 M(-5.1%) |
| Mar 2015 | - | $54.28 M(+68.3%) |
| Dec 2014 | $32.25 M(+104.3%) | $32.25 M(+18.2%) |
| Sept 2014 | - | $27.28 M(-12.4%) |
| June 2014 | - | $31.14 M(-10.1%) |
| Mar 2014 | - | $34.64 M(+119.5%) |
| Dec 2013 | $15.78 M(+0.2%) | $15.78 M(-2.7%) |
| Sept 2013 | - | $16.22 M(-10.6%) |
| June 2013 | - | $18.14 M(-15.7%) |
| Mar 2013 | - | $21.52 M(+36.6%) |
| Dec 2012 | $15.75 M(-22.8%) | $15.75 M(-19.4%) |
| Sept 2012 | - | $19.55 M(-21.5%) |
| June 2012 | - | $24.90 M(-16.3%) |
| Mar 2012 | - | $29.74 M(+45.8%) |
| Dec 2011 | $20.40 M | $20.40 M(-15.2%) |
| Sept 2011 | - | $24.06 M(-14.8%) |
| June 2011 | - | $28.23 M(-11.8%) |
| Mar 2011 | - | $32.01 M |
FAQ
- What is BioLineRx annual working capital?
- What is the all time high annual working capital for BioLineRx?
- What is BioLineRx annual working capital year-on-year change?
- What is BioLineRx quarterly working capital?
- What is the all time high quarterly working capital for BioLineRx?
- What is BioLineRx quarterly working capital year-on-year change?
What is BioLineRx annual working capital?
The current annual working capital of BLRX is $16.33 M
What is the all time high annual working capital for BioLineRx?
BioLineRx all-time high annual working capital is $47.69 M
What is BioLineRx annual working capital year-on-year change?
Over the past year, BLRX annual working capital has changed by -$24.99 M (-60.48%)
What is BioLineRx quarterly working capital?
The current quarterly working capital of BLRX is $12.89 M
What is the all time high quarterly working capital for BioLineRx?
BioLineRx all-time high quarterly working capital is $57.16 M
What is BioLineRx quarterly working capital year-on-year change?
Over the past year, BLRX quarterly working capital has changed by -$1.19 M (-8.47%)